Athira Pharma, Inc.
ATHA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $23 | $92 | $120 | $481 |
| - Cash | $48 | $91 | $96 | $111 |
| + Debt | $1 | $2 | $2 | $2 |
| Enterprise Value | -$25 | $3 | $26 | $372 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | -$0 |
| % Margin | – | – | – | – |
| EBITDA | -$96 | -$126 | -$88 | -$54 |
| % Margin | – | – | – | – |
| Net Income | -$97 | -$118 | -$96 | -$55 |
| % Margin | – | – | – | – |
| EPS Diluted | -25.2 | -30.9 | -25.3 | -14.9 |
| % Growth | 18.4% | -22.1% | -69.8% | – |
| Operating Cash Flow | -$97 | -$101 | -$72 | -$43 |
| Capital Expenditures | -$0 | -$0 | -$1 | -$2 |
| Free Cash Flow | -$97 | -$101 | -$74 | -$45 |